Not logged in.png)
Share.png)
SaveShare Save Share Save Share Save Share Save Share Save Share Save Share Save High-dose oxaliplatin induces severe hypersensitivity reactions and high recurrence rates during rechallenge in patients treated with hepatic arterial infusion chemotherapy
Liu, Baojiang; Gao, Song; Guo, Jianhai; Kou, Fuxin; Liu, Shaoxing; Zhang, Xin; Feng, Aiwei; Wang, Xiaodong; Cao, Guang; Xu, Liang; Chen, Hui; Liu, Peng; Xu, Haifeng; Gao, Qinzong; Yang, Renjie; Zhu, Xu Share Save Efficacy and Safety of HepaSphere Drug-Eluting Bead Transarterial Chemoembolization Combined with Hepatic Arterial Infusion Chemotherapy as the Second-Line Treatment in Advanced Hepatocellular CarcinomaLiu, Baojiang; Gao, Song; Guo, Jianhai; Kou, Fuxin; Liu, Shaoxing; Zhang, Xin; Feng, Aiwei; Wang, Xiaodong; Cao, Guang; Chen, Hui; Liu, Peng; Xu, Haifeng; Gao, Qinzong; Yang, Renjie; Xu, Liang; Zhu, Xu Share Save First-in-human study to evaluate the safety, tolerability, and population pharmacokinetic/pharmacodynamic target attainment analysis of FL058 alone and in combination with meropenem in healthy subjectsHuang, Zhiwei; Yang, Xinyi; Jin, Yi; Yu, Jicheng; Cao, Guoying; Wang, Jingjing; Hu, Yingying; Dai, Jingyi; Wu, Jufang; Wei, Qiong; Tian, Yan; Yu, Shuyan; Zhu, Xu; Mao, Xiaomeng; Liu, Wei; Liang, Hong; Zheng, Shansong; Ju, Yunfei; Wang, Zenghua; Zhang, Jing; Wu, Xiaojie Share Save Chinese expert consensus on the overall management of liver function in conversion therapy for liver cancer (2022 edition)Meng, Qinghua; Yang, Zhengqiang; Zhu, Zhenyu; Li, Juan; Bi, Xinyu; Chen, Xiao; Hao, Chunyi; Huang, Zhen; Li, Fei; Li, Xiao; Li, Guangming; Yang, Yinmo; Zhang, Yefan; Zhao, Haitao; Zhao, Hong; Zhu, Xu; Zhu, Jiye; Cai, Jianqiang Share Save Complementarity-determining region clustering may cause CAR-T cell dysfunctionSaren, Tina; Saronio, Giulia; Marti Torrell, Paula; Zhu, Xu; Thelander, Josefin; Andersson, Yasmin; Hofstrom, Camilla; Nestor, Marika; Dimberg, Anna; Persson, Helena; Ramachandran, Mohanraj; Yu, Di; Essand, Magnus Share Save A randomized phase II trial of hepatic arterial infusion of oxaliplatin plus raltitrexed versus oxaliplatin plus 5-fluorouracil for unresectable colorectal cancer liver metastasesFeng, Ai-Wei; Guo, Jian-Hai; Gao, Song; Kou, Fu-Xin; Liu, Shao-Xing; Liu, Peng; Chen, Hui; Wang, Xiao-Dong; Xu, Hai-Feng; Cao, Guang; Zhu, Xu Share Save Phase 2 Study of the PD-1 Inhibitor Serplulimab Plus the Bevacizumab Biosimilar HLX04 in Patients with Previously Treated Advanced Hepatocellular CarcinomaRen, Zhengang; Shao, Guoliang; Shen, Jie; Zhang, Li; Zhu, Xu; Fang, Weijia; Sun, Guoping; Bai, Yuxian; Wu, Jianbing; Liu, Lianxin; Yuan, Yuan; Zhang, Jingdong; Li, Zhen; Zhang, Ling; Yin, Tao; Wu, Jincai; Hou, Xiaoli; Wang, Qingyu; Zhu, Jun; Fan, Jia Share Save Sorafenib Plus Hepatic ArterialInfusion Chemotherapy versus Sorafenib for Hepatocellular Carcinoma with Major Portal Vein Tumor Thrombosis: A Randomized TriaLZheng, Kanglian; Zhu, Xu; Fu, Shijie; Cao, Guang; Li, Wen-Qing; Xu, Liang; Chen, Hui; Wu, Di; Yang, Renjie; Wang, Kun; Liu, Wei; Wang, Hongwei; Bao, Quan; Liu, Ming; Hao, Chunyi; Shen, Lin; Xing, Baocai; Wang, Xiaodong Share Save Signal enhancement ratio of CE-MRI: a potential biomarker of survival after hepatic arterial infusion chemotherapy in biliary tract cancersZheng, Kanglian; Fu, Shijie; Leng, Boyu; Cui, Yong; Yang, Renjie; Cao, Guang; Xu, Liang; Li, Wen-Qing; Li, Ying; Zhu, Xu; Gao, Song; Liu, Peng; Wang, Xiaodong Share Save Lenvatinib with or without Concurrent Drug-Eluting Beads Transarterial Chemoembolization in Patients with Unresectable, Advanced Hepatocellular Carcinoma: A Real-World, Multicenter, Retrospective StudyXia, Dongdong; Bai, Wei; Wang, Enxin; Li, Jiaping; Chen, Xiaoming; Wang, Zhexuan; Huang, Mingsheng; Huang, Ming; Sun, Junhui; Yang, Weizhu; Lin, Zhengyu; Wu, Jianbing; Li, Zixiang; Yang, Shufa; Zhu, Xu; Chen, Zaizhong; Zhang, Yanfang; Fan, Wenzhe; Mai, Qicong; Ding, Rong; Nie, Chunhui; Feng, Long; Li, Xueda; Huang, Wukui; Sun, Jun; Wang, Qiuhe; Lv, Yong; Li, Xiaomei; Luo, Bohan; Wang, Zhengyu; Yuan, Jie; Guo, Wengang; Li, Kai; Li, Bing; Li, Ruijun; Yin, Zhanxin; Xia, Jielai; Han, Guohong Share Save Systemic Therapy for Hepatocellular Carcinoma: Chinese Consensus-Based Interdisciplinary Expert StatementsSun, Yongkun; Zhang, Wen; Bi, Xinyu; Yang, Zhengqiang; Tang, Yu; Jiang, Liming; Bi, Feng; Chen, Minshan; Cheng, Shuqun; Chi, Yihebali; Han, Yue; Huang, Jing; Huang, Zhen; Ji, Yuan; Jia, Liqun; Jiang, Zhichao; Jin, Jing; Jin, Zhengyu; Li, Xiao; Li, Zhiyu; Liang, Jun; Liu, Lianxin; Liu, Yunpeng; Lu, Yinying; Lu, Shichun; Meng, Qinghua; Niu, Zuoxing; Pan, Hongming; Qin, Shukui; Qu, Wang; Shao, Guoliang; Shen, Feng; Song, Tianqiang; Song, Yan; Tao, Kaishan; Tian, Aiping; Wang, Jianhua; Wang, Wenling; Wang, Zhe; Wu, Liqun; Xia, Feng; Xing, Baocai; Xu, Jianming; Xue, Huadan; Yan, Dong; Yang, Lin; Ying, Jianming; Yun, Jingping; Zeng, Zhaochong; Zhang, Xuewen; Zhang, Yanqiao; Zhang, Yefan; Zhao, Jianjun; Zhou, Jianguo; Zhu, Xu; Zou, Yinghua; Dong, Jiahong; Fan, Jia; Lau, Wan Yee; Sun, Yan; Yu, Jinming; Zhao, Hong; Zhou, Aiping; Cai, Jianqiang Share Save Hepatic Artery Injection of 131I-Metuximab Combined with Transcatheter Arterial Chemoembolization for Unresectable Hepatocellular Carcinoma: A Prospective Nonrandomized, Multicenter Clinical TrialChen, Hui; Nan, Gang; Wei, Ding; Zhai, Ren-You; Huang, Ming; Yang, Wu-Wei; Xing, Bao-Cai; Zhu, Xu; Xu, Hai-Feng; Wang, Xiao-Dong; Zhang, Xiao-Yong; Zhu, Bao-Rang; Liu, Peng; Cao, Guang; Gao, Song; Hao, Chun-Yi; Yang, Ren-Jie; Guo, Jian-Hai; Zhang, Xin; Gao, Kun; Wang, Kun; Wang, Jian-Feng; Li, Zi-Yu; Zhu, Lin-Zhong; Ding, Rong; Li, Jing; Zhao, Ling; Shao, Yu-Jun; Liu, Hai-Chun; Xia, Jie-Lai; Wang, Ling; Kong, Ling-Min; Chen, Zhi-Nan; Bian, Huijie Share Save 
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}
.png){kind=icon}